Preclinical pk/pd profile, biomarker identification and rationale for indication selection of exoaso-stat6 (tm), a selective tumorassociated macrophage targeting candidate
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要